Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01154374 · ClinicalTrials.gov registry record · Phase 2
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
A Phase 2 study, sponsored by Skingenix.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT01154374: Completed Phase 2 study, sponsored by Skingenix.
NCT01154374 is a Phase 2 study that has completed, run by Skingenix. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01154374, a Phase 2 study, has completed, sponsored by Skingenix.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).
Interventions
- DRUG MEBO Wound Ointment
- PROCEDURE Standard of Care (sterile saline moistened gauze)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
What the finished NCT01154374 record still lists
NCT01154374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which MEBO Wound Ointment is the first listed.
NCT01154374 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01154374 about?
NCT01154374 is a clinical study titled "A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)". The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).
What is the current status of trial NCT01154374?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2010-11. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01154374?
The interventions under investigation include: MEBO Wound Ointment (DRUG), Standard of Care (sterile saline moistened gauze) (PROCEDURE).
Who is sponsoring clinical trial NCT01154374?
This trial is sponsored by Skingenix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01154374's enrollment target sits among peer trials
7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia